NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Instruments & Supplies · USD

Avantor, Inc. (AVTR) Stock Analysis

Avantor, Inc. (AVTR) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

AVTR

$14.97

−$0.22 (−1.45%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AVTR with… →

AVTR Key Statistics

As of Sep 4, 2026
Trading
Open
$15.13
Previous Close
$15.19
Day's Range
14.85–15.18
52-Week Range
7.27–15.93
Volume
7.65M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.90
Valuation
Market Cap
$10.13B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
16.98
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.54
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.84
Financials (FY)
Revenue (FY)
$6.55B−3.41%
Net Income (FY)
−$530.20M−174.52%
Profit marginThe share of revenue left as profit after all costs and taxes.
−8.81%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
676.36M
1-Year Return
+13.50%
Dividend and dates
Earnings Date
October 28, 2026
Avg Volume
9.39M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AVTR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+30.63%
2025−45.61%
2024−7.71%
2023+8.25%
2022−49.95%
2021+49.70%
2020+55.10%
2019 (partial year)+25.17%

As of September 4, 2026.

AVTR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$6.55B−$530.20M−8.1%
2024$6.78B$711.50M10.5%
2023$6.97B$321.10M4.6%
2022$7.51B$686.50M9.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$6.55B$2.14B$543.90M−$530.20M−8.1%
2024$6.78B$2.28B$638.20M$711.50M10.5%
2023$6.97B$2.36B$857.20M$321.10M4.6%
2022$7.51B$2.60B$1.13B$686.50M9.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AVTR Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricAVTRMedical Instruments & Supplies medianvs median
P/S ratio1.543.1751% below
Profit margin−8.81%0.85%9.7 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Avantor, Inc. (AVTR) is capitalised at $10.13B on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 13,500.

The most recent close on file for AVTR is $14.97, dated September 4, 2026. That is −$0.22 (−1.45%) against the previous close. Over the past 52 weeks the price has ranged from $7.27 to $15.93. The latest close sits 106.06% above that 52-week low.

Financial Health

In fiscal 2025, Avantor, Inc. reported revenue of $6.55B. That is −3.41% against the prior fiscal year, when revenue was $6.78B. The same year closed with a net loss of $530.20M. Profit margin runs at −8.81%. That is 9.7 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −0.84.

Across the 4 fiscal years on file, revenue moves from $7.51B in 2022 to $6.55B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 16.98. The price-to-sales ratio is 1.54. On price-to-sales that is 51.36% below the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.9. Daily returns over the trailing 7 years annualize to a volatility of 43.79%. Over the trailing twelve months the price has returned +13.50%. Measured over 5 years, that is −18.14% a year compounded.

Growth & Income

The record shows no dividend for AVTR.

So far in 2026 the price is +30.63%. Across the complete calendar years on file, 2020 returned +55.10% and 2022 returned −49.95%. Of the 6 complete calendar years on file, 3 finished higher.

Peer Comparison

Avantor, Inc. (AVTR) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Avantor, Inc. AVTR $10.13B —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Avantor, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Avantor, Inc.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Visit website →